Shionogi Clinical Trials Administrator Clinical Support Help Line
Shionogi
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
66
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Shionogi Clinical Trials Administrator Clinical Support Help Line as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06746051 · A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric ParticipantsShionogi · completed · RSV Infections · study director
- Ph1/Ph2NCT05588323 · Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving OpioidsShionogi · recruiting · Opioid-Induced Constipation (OIC) · study director
- Ph3NCT05568615 · Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALSShionogi · completed · ALS · study director
- Ph1NCT05342597 · Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)Shionogi · completed · Healthy Adult Subjects · study director
- Ph3NCT05151471 · Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALSShionogi · terminated · ALS · study director
- Ph1/Ph2NCT05101070 · S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid TumorsShionogi · recruiting · Solid Tumors · study director
- Ph1NCT04776135 · Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric TubeShionogi · completed · Healthy Adult Subjects · study director
- Ph1NCT04631354 · Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler DeviceShionogi · completed · Healthy Volunteer · study director
- N/ANCT04607707 · Women's Satisfaction and Adherence to Vulvovaginal Atrophy TreatmentsShionogi · completed · Vulvovaginal Atrophy · study director
- Ph3NCT04577404 · Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)Shionogi · completed · Amyotrophic Lateral Sclerosis (ALS) · study director
- Ph3NCT04569084 · Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALSShionogi · terminated · ALS · study director
- Ph1NCT04493281 · Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult SubjectsShionogi · completed · Healthy Adult Subjects · study director
- Ph1NCT04481789 · Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)Shionogi · completed · Healthy Adult Subjects · study director
- Ph1NCT04481750 · Study of Oral Edaravone in Healthy Adult MalesShionogi · completed · Healthy Adult Subjects · study director
- Ph2NCT04355169 · A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel TransectionShionogi · terminated · Postoperative Gastrointestinal Dysfunction · study director
- Ph2NCT04335539 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric ParticipantsShionogi · completed · Gram-negative Bacterial Infections, Bloodstream Infections (BSI), Complicated Intra-abdominal Infection (cIAI) · study director
- Ph1NCT04316689 · First-in-human Study of S-588210 (S-488210+S-488211)Shionogi · completed · Lung Cancer, Head and Neck Cancer, Bladder Cancer · study director
- Ph1NCT04254913 · Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With GastrostomyShionogi · completed · Japanese Patients With ALS · study director
- Ph2NCT04215991 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric ParticipantsShionogi · completed · Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), Complicated Urinary Tract Infection (cUTI) · study director
- Ph1NCT04176224 · Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral SclerosisShionogi · completed · Japanese Patients With ALS · study director
- Ph3NCT04165824 · Safety Study of Oral Edaravone Administered in Subjects With ALSShionogi · completed · ALS · study director
- Ph1NCT04147715 · Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy AdultsShionogi · completed · Healthy Volunteer · study director
- Ph2NCT04110054 · Evaluation of S-600918 in Adults With Refractory Chronic CoughShionogi · completed · Chronic Cough · study director
- Ph1NCT04029090 · A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy SubjectsShionogi · completed · Healthy Adult Subjects · study director
- Ph1NCT03897413 · Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult VolunteersShionogi · completed · Healthy Volunteer · study director
- Ph1NCT03862040 · Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial PneumoniaShionogi · terminated · Bacterial Pneumonia · study director
- N/ANCT03780140 · Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial InfectionsShionogi · approved for marketing · Bacterial Infections · study director
- Ph1NCT03664544 · PK Study in Subjects With Severe Hepatic ImpairmentShionogi · completed · Severe Hepatic Impairment, Healthy · study director
- Ph3NCT03395353 · A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive DisorderShionogi · terminated · Depressive Disorder · study director
- Ph2NCT03346538 · Dose Finding Study of MCI-186 in Acute Ischemic StrokeShionogi · terminated · Acute Ischemic Stroke · study director
- Ph1NCT03289234 · Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic ImpairmentShionogi · completed · Hepatic Impairment, Healthy · study director
- Ph1NCT03289208 · Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal ImpairmentShionogi · completed · Renal Impairment, Healthy · study director
- Ph3NCT03032380 · Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative PathogensShionogi · completed · Healthcare-associated Pneumonia (HCAP), Hospital Acquired Pneumonia (HAP), Ventilator Associated Pneumonia (VAP) · study director
- Ph3NCT02949011 · Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza ComplicationsShionogi · completed · Influenza · study director
- Ph3NCT02714595 · Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative PathogensShionogi · completed · Healthcare-associated Pneumonia (HCAP), Bloodstream Infections (BSI), Hospital Acquired Pneumonia (HAP) · study director
- Ph3NCT02638337 · Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to MenopauseShionogi · completed · Vaginal Dryness · study director
- Ph3NCT02389621 · Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive ProceduresShionogi · completed · Chronic Liver Disease, Thrombocytopenia · study director
- Ph2NCT02321800 · A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract InfectionsShionogi · completed · Urinary Tract Infections · study director
- Ph3NCT01993940 · Efficacy and Safety of Naldemedine in Treating Opioid-induced ConstipationShionogi · completed · Opioid-induced Constipation · study director
- Ph3NCT01965652 · Long Term Safety of NaldemedineShionogi · completed · Opioid-induced Constipation · study director
- Ph3NCT01965158 · Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced ConstipationShionogi · completed · Opioid-induced Constipation · study director
- Ph2NCT01651871 · Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic RhinitisShionogi · completed · Seasonal Allergic Rhinitis · study director
- Ph3NCT01585558 · Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact UterusShionogi · completed · Atrophy, Vaginal Diseases · study director
- Ph3NCT01492686 · Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral SclerosisShionogi · completed · Amyotrophic Lateral Sclerosis (ALS) · study director
- Ph2NCT01443403 · A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid TherapyShionogi · completed · Opioid-induced Constipation · study director
- Ph4NCT01439126 · Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity DisorderConcordia Pharmaceuticals Inc., Barbados · completed · Attention Deficit Hyperactivity Disorder · study director
- Ph2NCT01240759 · Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin TherapyShionogi · completed · Type 2 Diabetes Mellitus · study director
- Ph1NCT01184105 · A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature EjaculationPlethora Solutions Ltd · completed · Premature Ejaculation · study director
- Ph1NCT01183208 · A Safety and Tolerability Study of Administration of PSD502Plethora Solutions Ltd · completed · Premature Ejaculation · study director
- Ph2NCT01129024 · An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)Shionogi · terminated · Immune Thrombocytopenia · study director
- Ph2NCT01122030 · Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic PainShionogi · completed · Opioid Induced Bowel Dysfunction · study director
- Ph2NCT01054443 · A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)Shionogi · terminated · Immune Thrombocytopenia (ITP) · study director
- Ph2NCT00821821 · Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic StrokeShionogi · completed · Acute Ischemic Stroke (AIS) · study director
- Ph2NCT00788528 · Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese SubjectsShionogi · completed · Obesity · study director
- Ph2NCT00748605 · Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie DietShionogi · completed · Obesity · study director
- Ph2NCT00747929 · Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie DietShionogi · completed · Obesity · study director
- Ph3NCT00723190 · Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)Shionogi · completed · Attention Deficit Hyperactivity Disorder · study director
- Ph2NCT00703573 · A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic DermatitisShionogi · completed · Atopic Dermatitis · study director
- Ph1/Ph2NCT00697710 · A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic DermatitisShionogi · completed · Atopic Dermatitis · study director
- Ph2NCT00630539 · A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal WomenShionogi · completed · Atrophy, Vaginal Diseases · study director
- Ph3NCT00491894 · Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic ConditionsShionogi · completed · Cerebral Palsy, Neurological Conditions, Mental Retardation · study director
- Ph3NCT00424463 · Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)Shionogi · completed · Amyotrophic Lateral Sclerosis (ALS) · study director
- Ph3NCT00415519 · Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification IIIShionogi · completed · Amyotrophic Lateral Sclerosis (ALS) · study director
- Ph3NCT00330681 · Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)Shionogi · completed · Amyotrophic Lateral Sclerosis (ALS) · study director
- Ph3NCT00276094 · A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal WomenShionogi · completed · Atrophy, Vaginal Diseases · study director
- Ph4NCT00200356 · Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic StrokeShionogi · completed · Cerebral Infarction · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.